1. Home
  2. SEER vs AVXL Comparison

SEER vs AVXL Comparison

Compare SEER & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

N/A

Current Price

$1.56

Market Cap

113.0M

Sector

Health Care

ML Signal

N/A

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

N/A

Current Price

$0.93

Market Cap

115.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SEER
AVXL
Founded
2017
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
113.0M
115.9M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
SEER
AVXL
Price
$1.56
$0.93
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $4.00
N/A
AVG Volume (30 Days)
142.8K
★ 1.0M
Earning Date
11-10-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 9.40
N/A
EPS
N/A
★ N/A
Revenue
★ $16,578,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$20.50
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 16.99
N/A
52 Week Low
$1.55
$0.98
52 Week High
$2.38
$5.36

Technical Indicators

Market Signals
Indicator
SEER
AVXL
Relative Strength Index (RSI) 27.98 26.92
Support Level N/A N/A
Resistance Level $1.85 $1.60
Average True Range (ATR) 0.12 0.09
MACD -0.02 0.01
Stochastic Oscillator 5.45 9.24

Price Performance

Historical Comparison
SEER
AVXL

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: